Pfizer Inc (NYSE:PFE) has a beta value of 0.53 and has seen 4.82 million shares traded in the recent trading session. The company, currently valued at $136.59B, closed the recent trade at $53060000.0 per share which meant it gained $53059976.03 on the day or 4820379% during that session. The PFE stock price is 100.0% off its 52-week high price of $31.54 and 100.0% above the 52-week low of $20.92.
The consensus among analysts is that Pfizer Inc (PFE) is Buy stock at the moment, with a recommendation rating of 2.44. 1 analysts rate the stock as a Sell, while 1 rate it as Overweight. 7 out of 16 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight.
Pfizer Inc (NYSE:PFE) trade information
Over the past 30 days, the shares of Pfizer Inc (NYSE:PFE) have changed 4.28%.
Wall Street analysts have a consensus price target for the stock at $24, which means that the shares’ value could drop -221083233.33% from the levels at last check today.. The projected low price target is $24.0 while the price target rests at a high of $24.0. In that case, then, we find that the latest price level in today’s session is 100.0% off the targeted high while a plunge would see the stock lose 100.0% from the levels at last check today..
Pfizer Inc (PFE) estimates and forecasts
The company’s shares have lost -9.10% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -13.25% over the past 5 years. Earnings growth for 2025 is a modest -3.50% while over the next 5 years, the company’s earnings are expected to decrease by -0.27%.
PFE Dividends
Pfizer Inc is expected to release its next earnings report on 2025-Apr-29 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 1.70 at a share yield of 7.08%. The company’s dividend yield has gone up over the past 12 months.
Pfizer Inc (NYSE:PFE)’s Major holders
Insiders own 0.06% of the company shares, while shares held by institutions stand at 67.59% with a share float percentage of 67.63%. Investors are also buoyed by the number of investors in a company, with Pfizer Inc having a total of 3692.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 511.4 million shares worth more than $14.31 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.0258% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 424.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.87 billion and represent 7.4899% of shares outstanding.
